Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
10-2014 | 07-2014 | 04-2014 | 01-2014 | 10-2013 | |
Sales | 0 | 0 | 1,000 | 0 | 0 |
Gross Profit | N/A | N/A | 1,000 | N/A | N/A |
Operating Expenses | 0 | 5,999 | 3,596 | 5,958 | 0 |
Operating Income | N/A | -5,999 | -2,596 | -5,958 | N/A |
Interest Expense | 0 | 0 | 3 | 2 | 0 |
Other Income | 0 | 220 | 285 | 147 | 0 |
Pre-tax Income | 0 | -5,779 | -2,315 | -5,813 | 0 |
Income Tax | N/A | N/A | N/A | -626 | N/A |
Net Income Continuous | N/A | -5,779 | -2,315 | -5,187 | N/A |
Net Income | $N/A | $-5,779 | $-2,315 | $-5,187 | $N/A |
EPS Basic Total Ops | N/A | -359.82 | -179.91 | -443.78 | N/A |
EPS Basic Continuous Ops | N/A | -359.65 | -176.27 | -449.48 | N/A |
EPS Diluted Total Ops | N/A | -359.82 | -179.91 | -443.78 | N/A |
EPS Diluted Continuous Ops | N/A | -359.65 | -176.27 | -449.48 | N/A |
EBITDA(a) | $N/A | $-5,947 | $-2,546 | $-5,909 | $N/A |